Cargando…
Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications
The past few years have shown an ongoing interest in lipoprotein(a) (Lp(a)), a lipid molecule that has been proven to have atherogenic, thrombogenic, and inflammatory properties. Several lines of evidence, indeed, have demonstrated an increased risk of cardiovascular disease as well as calcific aort...
Autores principales: | Koutsogianni, Amalia Despoina, Liamis, George, Liberopoulos, Evangelos, Adamidis, Petros Spyridonas, Florentin, Matilda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222947/ https://www.ncbi.nlm.nih.gov/pubmed/37242533 http://dx.doi.org/10.3390/ph16050750 |
Ejemplares similares
-
Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2022) -
Statin-associated side effects in patients attending a lipid clinic: evidence from a 6-year study
por: Barkas, Fotios, et al.
Publicado: (2021) -
Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin–Therapy: A 6-Year Retrospective Study
por: Anastasiou, Georgia, et al.
Publicado: (2023) -
An overview of diagnosis and management of drug‐induced hypomagnesemia
por: Liamis, George, et al.
Publicado: (2021) -
Hyponatremia in Patients with Hematologic Diseases
por: Koumpis, Epameinondas, et al.
Publicado: (2020)